APA (7th ed.) Citation

G, P., A, M., A, R., B, R., H, S., T, K., . . . T, N. (2024). Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial. Nature medicine, 30(12), 3669. https://doi.org/10.1038/s41591-024-03270-6

Chicago Style (17th ed.) Citation

G, Pagano, et al. "Sustained Effect of Prasinezumab on Parkinson's Disease Motor Progression in the Open-label Extension of the PASADENA Trial." Nature Medicine 30, no. 12 (2024): 3669. https://doi.org/10.1038/s41591-024-03270-6.

MLA (9th ed.) Citation

G, Pagano, et al. "Sustained Effect of Prasinezumab on Parkinson's Disease Motor Progression in the Open-label Extension of the PASADENA Trial." Nature Medicine, vol. 30, no. 12, 2024, p. 3669, https://doi.org/10.1038/s41591-024-03270-6.